<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35608079</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1537-4521</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>24</Day>
            </PubDate>
          </JournalIssue>
          <Title>Sexually transmitted diseases</Title>
          <ISOAbbreviation>Sex Transm Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Assessing the impact of HIV pre-exposure prophylaxis scale-up on gonorrhea incidence among gay and bisexual men in Sydney: a mathematical modelling study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1097/OLQ.0000000000001649</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The rollout of pre-exposure prophylaxis (PrEP) for HIV prevention among gay and bisexual men (GBM) is associated with increases in condomless anal intercourse, potentially increasing incidence of other sexually transmissible infections (STIs).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We developed an individual-based mathematical model to simulate the transmission of Neisseria gonorrhoeae (NG) among GBM in Sydney, accounting for changes in sexual practices, STI testing, and PrEP use. We calibrated and validated the model using reported incidence rates for HIV-positive and HIV-negative GBM during 2010 to 2019. Scenarios were run with varying PrEP uptake, PrEP-related STI testing, and PrEP-related sexual behavior and testing intervals up to 2030 to assess the impact of PrEP use on gonorrhea incidence.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">PrEP uptake and associated three-monthly STI testing from 2015 onwards resulted in a predicted increase from 20 to 37 NG infections per 100 person-years among HIV-negative GBM by the end of 2020. This is lower than the counterfactual predictions of 45 per 100 person-years if PrEP were not scaled up and 48 per 100 person-years with non-adherence to three-monthly STI testing. Increasing the time between STI tests for PrEP users by one month from 2018 results in the incidence rate among HIV-negative GBM increasing by 8% by 2030. If PrEP coverage doubles from 24% to 53%, incidence among HIV-negative GBM declines by ~25% by 2030.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Behavior change due to widespread PrEP use may lead to significant increases in gonorrhea incidence in GBM, but the recommended quarterly STI testing recommended for PrEP users should reduce incidence by 18% by 2030.</AbstractText>
          <CopyrightInformation>Copyright Â© 2022 American Sexually Transmitted Diseases Association. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Walker</LastName>
            <ForeName>Michael L</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>Kirby Institute, UNSW Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stiasny</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>UNSW Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guy</LastName>
            <ForeName>Rebecca J</ForeName>
            <Initials>RJ</Initials>
            <AffiliationInfo>
              <Affiliation>Kirby Institute, UNSW Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Law</LastName>
            <ForeName>Matthew G</ForeName>
            <Initials>MG</Initials>
            <AffiliationInfo>
              <Affiliation>Kirby Institute, UNSW Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Holt</LastName>
            <ForeName>Martin</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>UNSW Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mao</LastName>
            <ForeName>Limin</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>UNSW Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Donovan</LastName>
            <ForeName>Basil</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Kirby Institute, UNSW Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grulich</LastName>
            <ForeName>Andrew E</ForeName>
            <Initials>AE</Initials>
            <AffiliationInfo>
              <Affiliation>Kirby Institute, UNSW Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gray</LastName>
            <ForeName>Richard T</ForeName>
            <Initials>RT</Initials>
            <AffiliationInfo>
              <Affiliation>Kirby Institute, UNSW Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Regan</LastName>
            <ForeName>David G</ForeName>
            <Initials>DG</Initials>
            <AffiliationInfo>
              <Affiliation>Kirby Institute, UNSW Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Sex Transm Dis</MedlineTA>
        <NlmUniqueID>7705941</NlmUniqueID>
        <ISSNLinking>0148-5717</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>3</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35608079</ArticleId>
        <ArticleId IdType="doi">10.1097/OLQ.0000000000001649</ArticleId>
        <ArticleId IdType="pii">00007435-990000000-00029</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
